Brd4 Inhibition Suppresses HPV16 E6 Expression and Enhances Chemoresponse: A Potential New Target in Cervical Cancer Therapy

International Journal of Cancer- United States

doi 10.1002/ijc.31986

Full Text

Abstract

Available in

Categories

Cancer Research

Date

January 16, 2019

Authors

Juliane Haedicke-Jarboui

Frank Stubenrauch

Publisher

Wiley

Related search

Expression of Yin Yang 1 in Cervical Cancer and Its Correlation With E-Cadherin Expression and HPV16 E6

Multidisciplinary

English

HPV16 E6 Gene Variations in Invasive Cervical Squamous Cell Carcinoma and Cancer in Situ From Russian Patients

British Journal of Cancer

Cancer Research

English

The Role of HPV16 Regulatory Region Methylation in Viral Oncogenes E6 and E7 Eхpression in Primary Cervical Cancer Lesions

Advances in molecular oncology

English

Protein Kinase D as a Potential New Target for Cancer Therapy

Biochimica et Biophysica Acta - Reviews on Cancer

Cancer Research

English

Plasmid-Based E6-Specific siRNA and Co-Expression of Wild-Type P53 Suppresses the Growth of Cervical Cancer in Vitro and in Vivo

Cancer Research

English

Inhibition of BRD4 Suppresses the Malignancy of Breast Cancer Cells via Regulation of Snail

Cell Death and Differentiation

Molecular Biology

English

BRD4 Inhibition Enhances Azacitidine Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Frontiers in Oncology

Cancer Research

English

Human Papillomavirus E6/E7 and lncRNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells

Journal of Virology

English

Association of HPV16 E6 Variants With Diagnostic Severity in Cervical Cytology Samples of 354 Women in a US Population

International Journal of Cancer

Cancer Research

English